These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7730723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
    Gelber RH, Murray LP, Siu P, Tsang M, Rea TH.
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
    [Abstract] [Full Text] [Related]

  • 3. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH, Ji BH, Guelpa-Lauras CC, Perani EG, N'Deli LN.
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
    Naik SS, Bhanage ND, Sawant KV, Ganapati R.
    Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
    Katoch K, Katoch VM, Natarajan M, Gupta UD, Sharma VD, Singh HB.
    Indian J Lepr; 2008 Jul; 80(4):331-44. PubMed ID: 20329382
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Bhatia AS, Sreevatsa, Gupta UD, Sharma VD, Shivannavar CT, Patil MA, Bharadwaj VP.
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [Abstract] [Full Text] [Related]

  • 13. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN, Ebenezer G, Rao GS, Natrajan MM, Balasundaram B.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [Abstract] [Full Text] [Related]

  • 18. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH.
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [Abstract] [Full Text] [Related]

  • 19. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK, Girdhar A, Natrajan M, Kumar A, Girdhar BK.
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [Abstract] [Full Text] [Related]

  • 20. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
    Ebenezer GJ, Daniel S, Norman G, Daniel E, Job CK.
    Indian J Lepr; 2004 Sep; 76(3):199-206. PubMed ID: 15835604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.